Status:
COMPLETED
The Metabolic Response to Reduced Branched-chain Amino Acids in Humans
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Diabetes
Obesity
Eligibility:
MALE
35-65 years
Phase:
NA
Brief Summary
Branched-chain amino acids (BCAAs) are essential nutrients that the body obtains from proteins found in food, especially meat, diary products, and legumes. Data from rodent studies suggest that reduct...
Detailed Description
This study, which will be completed over three months, involves replacing two meals a day with meal replacement beverages for two months, with a one month follow-up visit. These beverages will be made...
Eligibility Criteria
Inclusion
- Male between the age of 35 - 65
- BMI between 28 - 35 (mildly obese/overweight)
- Fasting glucose level of 101 - 125 mg/dL
- Able and willing to give written informed consent
- Stable weight (within 5 lbs. for at least 3 months)
- Not taking (or willing to cease taking) over the counter vitamin/mineral supplements
- Not planning to begin an exercise or diet program
Exclusion
- Female
- Outside required age range of 35 - 65
- BMI not within range of 28 - 35
- Fasting glucose not within range of 101 - 125 mg/dL
- Use of prescription medications for diabetes or weight-loss
- Use of and unwillingness to discontinue over the counter supplements (e.g. cinnamon, chromium, protein powders) or weight loss beverage or meal plans (e.g. SlimFast or Jenny Craig).
- Low baseline albumin or pre-albumin levels (below normal reference range)
- Significant anemia (Hemoglobin \< 11 g/dL)
- Known bleeding disorder or platelet dysfunction
- Already eating a low protein diet (less than 14% total caloric intake from protein), as calculated from food diaries provided by subjects
- Participating in intensive exercise training program (high to moderate intensity exercise greater than 210 minutes per week) or planning to start new exercise program during study period.
- Significant co-morbidities (including kidney disease, liver disease, GI disease, cardiovascular disease, respiratory disease, malnutrition, substance abuse, psychiatric disease, or a diagnosed eating disorder).
- Planned smoking cessation or attempt at smoking cessation during study period
- Inability to tolerate meal replacement beverages due to palatability
- Recent weight loss (\> 5 lbs within 3 months).
- Bariatric surgery, gastric banding or liposuction
- Current or past (within 1 year) use of illicit drugs
- Claustrophobia
Key Trial Info
Start Date :
November 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2021
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT03239717
Start Date
November 28 2017
End Date
July 16 2021
Last Update
July 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, United States, 53726